セッション

The optimal plasma lenalidomide concentration and the function of NK cell in Ld therapy for MM

[演者] Takahiro Kobayashi (小林 敬宏):1
[著者] Masatomo Miura (三浦 昌朋):2, Takenori Niioka (新岡 丈典):2, Yuki Fujioka (藤岡 優樹):1,3, Maiko Abumiya (鐙屋 舞子):2, Hideaki Ohyagi (大八木 秀明):4, Yoshinori Shinohara (篠原 良徳):4, Mutsuhito Motegi (茂木 睦仁):5, Jun Kuroki (黒木 淳):6, Tamio Nishinari (西成 民夫):6, Yoshinari Kawabata (川端 良成):7, Atsushi Kitabayashi (北林 淳):7, Yoshihiro Michishita (道下 吉広):8, Sho Ikeda (池田 翔):1, Seiji Shida (志田 青慈):1, Tomoko Yoshioka (吉岡 智子):1, Hiroyoshi Nishikawa (西川 博嘉):3, Naoto Takahashi (高橋 直人):1
1:Hematol., Akita Univ., Akita, Japan, 2:Pharmacy, Akita Univ. Hosp., Akita, Japan, 3:Cancer Immunol., National Cancer Center, Chiba, Japan, 4:Hematol., Hiraka General Hosp., Akita, Japan, 5:Int Med., Omagari Kousei Medical Center, Akita, Japan, 6:Int. Med., Yuri Kumiai General Hospital, Akita, Japan, 7:Hematol., Akita Kousei Medical Center, Akita, Japan, 8:Hematol., Nohshiro Kousei Medical Center, Akita, Japan

Analysis of NK cell function in multiple myeloma patients

[演者] Shotaro Hagiwara (萩原 將太郎):1
[著者] Noriko Toyama-Sorimachi (反町 典子):2, Junji Tanaka (田中 淳司):1
1:Hematology, Tokyo Women's Medical Univ., Tokyo, Japan, 2:Reserch Institute, National Center for Global Health and Medicine

Comparison of MRD detection in autografts of multiple myeloma patients between EuroFlow and NGS

[演者] Hiroyuki Takamatsu (高松 博幸):1
[著者] Naoki Takezako (竹迫 直樹):2, Rachel Wee:1, Takeshi Yoroidaka (鎧高 健志):1, Takeshi Yamashita (山下 剛史):1,3, Ryoichi Murata (村田 了一):3, Jianbiao Zheng:4, Martin Moorhead:4, Victoria Carlton:4, Malek Faham:4, Shinji Nakao (中尾 眞二):1
1:Hematol. Kanazawa Univ., Kanazawa, Japan, 2:Disaster Medical Center of Japan, Tachikawa, Japan, 3:Keiju Kanazawa Hospital, Kanazawa, Japan, 4:Adaptive Biotechnologies Corp., South San Francisco, CA

Potent anti-tumor effect of combination therapy using AKT inhibitor and pomalidomide with DEX in MM

[演者] Shiori Kinoshita (木下 史緒理):1
[著者] Masaki Ri (李 政樹):1, Takashi Yoshida (吉田 嵩):1, Tomoko Narita (成田 朋子):1, Haruhito Totani (戸谷 治仁):1, Ashour Reham:1,2, Asahi Ito (伊藤 旭):1, Shigeru Kusumoto (楠本 茂):1, Takashi Ishida (石田 高司):1, Hirokazu Komatsu (小松 弘和):1, Shinsuke Iida (飯田 真介):1
1:Department of Hematology and Oncology, Nagoya City Univ., Nagoya, Japan, 2:Clinical Pathology, Qena University Hospital, South Valley University, Qena, Egypt

Cereblon-independent anti-myeloma pathway of TC11, a novel compound of immunomodulatory drugs

[演者] Misa Nakamura (中村 美沙):1
[著者] Daiju Ichikawa (市川 大樹):1, Shuji Aida (會田 宗司):1, Nahoko Hashimoto (橋本 菜帆子):1, Wakana Murota (室田 若菜):1, Ryo Uozaki (宇於崎 涼):1, Mikio Okayama (岡山 幹夫):2, Kota Fujimori (藤森 宏太):1, Yuko Yonemura (米村 裕子):3, Noriko Tabata (田畠 典子):3, Hiroshi Yanagawa (柳川 弘志):3, Maiko Matsushita (松下 麻衣子):1, Yutaka Hattori (服部 豊):1
1:Clin. Physiol. & Therapeutics, Keio Faculty of Pharmacy, Tokyo, Japan, 2:Division of Hematology, Keio University School of Medicine, Tokyo, Japan, 3:IDAC Theranostics Inc., Tokyo, Japan

詳細検索